New Study Identifies Promising Prognostic Marker for Advanced Lung Adenocarcinoma
Philadelphia, August 5, 2025 – A groundbreaking study published in The American Journal of Pathology unveils the pivotal role of ...
Philadelphia, August 5, 2025 – A groundbreaking study published in The American Journal of Pathology unveils the pivotal role of ...
Cancer’s relentless capacity to outmaneuver treatment remains one of the most formidable obstacles in modern medicine. Among the most vexing ...
In recent years, the quest to improve outcomes for glioblastoma (GB) patients has fueled intense research into novel therapeutic avenues, ...
In the dynamic landscape of cellular biology, oxygen availability stands as a fundamental determinant of cell fate, survival, and function. ...
In the relentless pursuit of combating gastric cancer, a disease notorious for its high mortality and global prevalence, new molecular ...
A rapidly evolving frontier in cancer biology reveals the profound influence of exosomes on the tumor microenvironment (TME), particularly through ...
In a groundbreaking advancement in ovarian cancer therapeutics, researchers have unveiled a pioneering gene immunotherapy approach leveraging adeno-associated virus (AAV) ...
The omentum is a common site of metastasis for many cancers originating from organs in the abdominal cavity, particularly epithelial ...
A Breakthrough in Breast Cancer Immunotherapy: Moffitt Cancer Center’s Vaccine Strategy At the forefront of cancer treatment innovation, researchers at ...
Pancreatic cancer remains a formidable adversary in the realm of oncology, characterized by its stealthy progression and dire prognosis. Among ...
In a dramatic revelation that challenges conventional thinking about cell biology, scientists report that cancer cells can effectively “poison” the ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.